APA (7th ed.) Citation

Zhe Liang, Qi Chen, Ruiqi Wei, Chenyao Ma, Xuehui Zhang, Xue Chen, . . . Quanming Zhao. (2021). Cost-Effectiveness of Alirocumab for the Secondary Prevention of Cardiovascular Events after Myocardial Infarction in the Chinese Setting. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Zhe Liang, Qi Chen, Ruiqi Wei, Chenyao Ma, Xuehui Zhang, Xue Chen, Fang Fang, and Quanming Zhao. Cost-Effectiveness of Alirocumab for the Secondary Prevention of Cardiovascular Events After Myocardial Infarction in the Chinese Setting. Frontiers Media S.A., 2021.

MLA (9th ed.) Citation

Zhe Liang, et al. Cost-Effectiveness of Alirocumab for the Secondary Prevention of Cardiovascular Events After Myocardial Infarction in the Chinese Setting. Frontiers Media S.A., 2021.